May 18, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges
Share
Aa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges
Biotechnology

Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges

By Newsroom April 5, 2025 1 Min Read
Share


On February 28, 2025, the U.S. Patent and Trademark Office announced that it was rescinding a 2022 memorandum that provided guidance regarding the application of the Apple v. Fintiv decision to the Patent Trial and Appeal Board’s discretion to deny patent challenges with pending parallel district court litigation. The PTO has referred parties back to precedent for guidance including Apple Inc. v. Fintiv, Inc. Rescinding the 2022 memorandum also has the effect of effectively removing the proposed rules related to discretionary denial that were under consideration as recently as last year.

35 U.S.C. § 314(a) provides the…



Source link

Share This Article
Facebook Twitter Email Copy Link Print

HOT NEWS

CP Railway had no legal liability for Lac-Mégantic disaster

Environmental Science
April 5, 2025

&D

 Segmentation of Inorganic Pyrophosphatase Market(PharmaNewsWire.Com, May 17, 2025 ) InsightAce Analytic Pvt. Ltd. announces the…

May 17, 2025

As Part of the “AfriSummit 2024” Activities A High-Level Meeting between Uganda and Egypt to Strengthen Pharmaceutical Cooperation and Expand the African Market

A high-level meeting between Uganda and Egypt to strengthen pharmaceutical cooperation CAIRO, Egypt (AfricaNewswire.Net) —…

April 5, 2025

ضمن فعاليات “قمة إفريقيا للشؤون التنظيمية 2024” اجتماع رفيع بين أوغندا ومصر لتعزيز التعاون الدوائي وتوسيع السوق الإفريقية

اجتماع رفيع المستوى بين أوغندا ومصر لتعزيز التعاون الصيدلاني القاهرة، مصر، نوفمبر 2024 (AfricaNewswire.Net)  في…

April 5, 2025

YOU MAY ALSO LIKE

Value and Risk of Overlapping Intellectual Property Protections

A well-orchestrated intellectual property strategy requires carefully and thoughtfully leveraging copyright, trademark, and patent laws, as highlighted by a recent…

Biotechnology
May 16, 2025

Extending the Patentable Life of 3D Printers: A Lesson From the Pharmaceutical Industry

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies…

Biotechnology
May 3, 2025

Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |

This post could have been “The Revival of the March-In Rights of the Bayh-Dole Act.” The passage of the Bayh-Dole…

Biotechnology
April 26, 2025

Patent Litigation and the Rise of Quantum Computing: What to Watch for in the Next Decade

A recent Patent Trial and Appeal Board decision related to hybrid quantum computing paves the way for more quantum computing-related…

Biotechnology
April 19, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

&D
May 17, 2025
Non Fungible Tokens in Healthcare Market Role in Data Management Genomics and Clinical Trials with Growth Prospects
May 17, 2025
Leukemia Inhibitory Factor Market Overview Emerging Therapeutic Applications and Industry Trends to 2034
May 17, 2025
Down to a Science: The Lab Manager's Guide to Real-Time…
May 17, 2025

Life Science Magazines

Down to a Science: The Lab Manager's Guide to Real-Time…
May 17, 2025
Introducing the Rapid Intervention Team from LabConnect
May 16, 2025
Oncology Expertise that Accelerates Your Clinical Trial
May 16, 2025
Accelerate Your Trials with Sample Collection Best Practices
May 16, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Lost your password?